{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:52:05Z","timestamp":1791492725986,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001513","name":"Breast Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trecan.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:11:43Z","timestamp":1790068303000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating tumor cell\u2013immune cell clusters: dynamic engines of metastasis"],"prefix":"10.1016","author":[{"given":"Fangjia","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Gradishar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-7995","authenticated-orcid":false,"given":"Huiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.09.003_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.trecan.2026.09.003_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: a question of life or death","volume":"6","author":"Mehlen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-020-00728-3","article-title":"Tracking cancer progression: from circulating tumor cells to metastasis","volume":"12","author":"Castro-Giner","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.trecan.2026.09.003_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2011.10.018","article-title":"Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer","volume":"76","author":"O\u2019Flaherty","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0025","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/annonc\/mdy172","article-title":"Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts","volume":"29","author":"Lorente","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-016-4026-2","article-title":"Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer","volume":"161","author":"Wang","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2026.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdn786","article-title":"Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0040","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2907","article-title":"Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment","volume":"13","author":"Giuliano","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0045","doi-asserted-by":"crossref","first-page":"24517","DOI":"10.1038\/srep24517","article-title":"Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients","volume":"6","author":"Tsai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12032-016-0875-0","article-title":"CTC clusters in cancer progression and metastasis","volume":"34","author":"Fabisiewicz","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","article-title":"Better together: circulating tumor cell clustering in metastatic cancer","volume":"7","author":"Schuster","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0060","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3892\/ijo.2016.3747","article-title":"Circulating tumor cell clusters: what we know and what we expect (review)","volume":"49","author":"Hong","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/0008-5472.CAN-17-2748","article-title":"Perspective on circulating tumor cell clusters: why it takes a village to metastasize","volume":"78","author":"Giuliano","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0070","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/ijms21072653","article-title":"Circulating tumor cell clusters: united we stand divided we fall","volume":"21","author":"Amintas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.09.003_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bj.2019.11.002","article-title":"Bring along your friends: homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis","volume":"43","author":"Aceto","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.trecan.2026.09.003_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/2767-9764.CRC-24-0498","article-title":"A melanoma brain metastasis CTC signature and CTC: B-cell clusters associate with secondary liver metastasis: a melanoma brain\u2013liver metastasis axis","volume":"5","author":"Bowley","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.trecan.2026.09.003_bb0085","article-title":"Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12876-022-02603-4","article-title":"Association of circulating tumor cell-white blood cell clusters with survival outcomes in patients with colorectal cancer after curative intent surgery","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0095","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1111\/1759-7714.14120","article-title":"Circulating tumor cells (CTCs)\/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: predictors for response and prognosis","volume":"12","author":"Zhu","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0100","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1186\/s12885-021-08463-7","article-title":"The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma","volume":"21","author":"Guan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0105","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.21037\/jtd-22-423","article-title":"Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer","volume":"14","author":"Li","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.trecan.2026.09.003_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.09.003_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12885-023-10985-1","article-title":"Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12951-025-03522-8","article-title":"Targeting circulating tumor cell\u2013neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis","volume":"23","author":"Su","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117474","article-title":"CTC-neutrophil interaction: a key driver and therapeutic target of cancer metastasis","volume":"180","author":"Hu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.trecan.2026.09.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193521","article-title":"Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis","volume":"135","author":"Scholten","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2026.09.003_bb0135","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1038\/s41467-025-62862-z","article-title":"Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis","volume":"16","author":"Schuster","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.09.003_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mehy.2015.12.007","article-title":"Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance","volume":"87","author":"Liu","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.trecan.2026.09.003_bb0145","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0150","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms20081916","article-title":"PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/Notch\/Nodal signaling","volume":"20","author":"Sprouse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.09.003_bb0155","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.3390\/cancers13184690","article-title":"Circulating tumour cell numbers correlate with platelet count and circulating lymphocyte subsets in men with advanced prostate cancer: data from the ExPeCT clinical trial (CTRIAL-IE 15-21)","volume":"13","author":"Hayes","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0160","article-title":"Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells","volume":"7","author":"Maurer","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trecan.2026.09.003_bb0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.09.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adw7698","article-title":"Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value","volume":"18","author":"Reduzzi","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.09.003_bb0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s43856-025-01024-0","article-title":"Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer","volume":"5","author":"Higa","year":"2025","journal-title":"Commun. Med. (Lond.)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0180","doi-asserted-by":"crossref","first-page":"14687","DOI":"10.3390\/ijms232314687","article-title":"Fusion cell markers in circulating tumor cells from patients with high-grade ovarian serous carcinoma","volume":"23","author":"Ruano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.09.003_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-024-01789-1","article-title":"Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.09.003_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells\u2014mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7150\/jca.103757","article-title":"TGF-\u03b2 secreted by cancer cells-platelets interaction activates cancer metastasis potential by inducing metabolic reprogramming and bioenergetic adaptation","volume":"16","author":"Zhong","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0205","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41598-018-19245-w","article-title":"Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer","volume":"8","author":"Dhar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0210","doi-asserted-by":"crossref","first-page":"31726","DOI":"10.1038\/srep31726","article-title":"Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab","volume":"6","author":"Nicolazzo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1438111","article-title":"Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy","volume":"7","author":"Yue","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trecan.2026.09.003_bb0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.trecan.2024.03.004","article-title":"Exploiting the metabolic vulnerability of circulating tumour cells","volume":"10","author":"Merteroglu","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cells13050441","article-title":"The role of oxidative stress in tumorigenesis and progression","volume":"13","author":"Li","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.trecan.2026.09.003_bb0230","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","article-title":"The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.09.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.trecan.2026.09.003_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-025-01777-0","article-title":"CBX3 confers ferroptosis resistance during blood-borne metastasis","volume":"19","author":"Wu","year":"2026","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/159269","article-title":"Myeloid-derived suppressor cells and therapeutic strategies in cancer","volume":"2015","author":"Katoh","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.trecan.2026.09.003_bb0250","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2026.09.003_bb0255","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2008.20.6664","article-title":"Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer","volume":"27","author":"Liu","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0260","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.09.003_bb0265","first-page":"1","article-title":"Circulating tumor cells as a predictor of treatment response in clinically localized prostate cancer","volume":"3","author":"Salami","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0270","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.09.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259586","article-title":"Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion","volume":"135","author":"Xu","year":"2022","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.trecan.2026.09.003_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1494723","article-title":"Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy","volume":"15","author":"Yadav","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0285","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/0008-5472.CAN-17-2459","article-title":"Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma","volume":"78","author":"Qi","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0290","doi-asserted-by":"crossref","first-page":"16787","DOI":"10.1021\/acs.analchem.1c03167","article-title":"Dynamic monitoring of EMT in CTCs as an indicator of cancer metastasis","volume":"93","author":"Zhang","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.trecan.2026.09.003_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1160185","article-title":"Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response","volume":"5","author":"Schauer","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trecan.2026.09.003_bb0310","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","article-title":"Immunometabolism in cancer: basic mechanisms and new targeting strategy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.trecan.2026.09.003_bb0315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/CM9.0000000000003738","article-title":"Microenvironment crosstalk and immune evasion of circulating tumor cells: from mechanism to clinical significance","volume":"139","author":"Chen","year":"2026","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.trecan.2026.09.003_bb0320","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","article-title":"ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer","volume":"12","author":"Taftaf","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.09.003_bb0325","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41591-024-03486-6","article-title":"Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial","volume":"31","author":"Kurzeder","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.09.003_bb0330","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0335","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.09.003_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166487","article-title":"Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0345","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/bjc.2011.294","article-title":"A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas","volume":"105","author":"Farace","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.09.003_bb0350","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cyto.a.23571","article-title":"The Parsortix\u2122 cell separation system\u2014a versatile liquid biopsy platform","volume":"93","author":"Miller","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.trecan.2026.09.003_bb0355","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","article-title":"Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?","volume":"39","author":"Gires","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.trecan.2026.09.003_bb0360","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","article-title":"Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system","volume":"13","author":"Riethdorf","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0365","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2015.12.002","article-title":"Challenges in circulating tumor cell detection by the CellSearch system","volume":"10","author":"Andree","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0370","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymeth.2013.06.019","article-title":"NanoVelcro chip for CTC enumeration in prostate cancer patients","volume":"64","author":"Lu","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.trecan.2026.09.003_bb0375","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nprot.2014.044","article-title":"Microfluidic, marker-free isolation of circulating tumor cells from blood samples","volume":"9","author":"Karabacak","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2026.09.003_bb0380","series-title":"Mammary Stem Cells: Methods and Protocols","first-page":"309","article-title":"Negative-selection enrichment of circulating tumor cells from peripheral blood using the microfluidic CTC-iChip","author":"Burr","year":"2022"},{"key":"10.1016\/j.trecan.2026.09.003_bb0385","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/ar5001617","article-title":"Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells","volume":"47","author":"Lin","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0390","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fbioe.2020.00897","article-title":"A new method for CTC images recognition based on machine learning","volume":"8","author":"He","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2016.04.014","article-title":"Imagestream detection and characterisation of circulating tumour cells\u2014a liquid biopsy for hepatocellular carcinoma?","volume":"65","author":"Ogle","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0400","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/apm.12061","article-title":"Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs ImageStream systems","volume":"121","author":"L\u00f3pez-Riquelme","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.trecan.2026.09.003_bb0405","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.3390\/cancers13246386","article-title":"Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (IsoFlux) and imaging flow cytometry (ImageStream)","volume":"13","author":"Ruiz-Rodr\u00edguez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0410","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.3390\/cancers13194862","article-title":"Clinical significance of circulating tumor cell induced epithelial-mesenchymal transition in patients with metastatic colorectal cancer by single-cell RNA-sequencing","volume":"13","author":"Kozuka","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0415","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/cancers14051314","article-title":"Single-cell RNA sequencing uncovers heterogeneous circulating tumor cell subsets in breast cancer","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10238-024-01309-z","article-title":"Research progress on the multi-omics and survival status of circulating tumor cells","volume":"24","author":"Xie","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.trecan.2026.09.003_bb0425","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.3390\/cancers15153949","article-title":"Cell state and cell type: deconvoluting circulating tumor cell populations in liquid biopsies by multi-omics","volume":"15","author":"Welter","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105081","article-title":"Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine","volume":"25","author":"Chen","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.trecan.2026.09.003_bb0435","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.1038\/srep12270","article-title":"The detection of EpCAM+ and EpCAM\u2013 circulating tumor cells","volume":"5","author":"Wit","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0440","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3390\/cancers17142289","article-title":"Establishing a highly accurate circulating tumor cell image recognition system for human lung cancer by pre-training on lung cancer cell lines","volume":"17","author":"Matsumiya","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.003_bb0445","doi-asserted-by":"crossref","first-page":"12226","DOI":"10.1038\/s41598-020-69056-1","article-title":"Label-free detection of rare circulating tumor cells by image analysis and machine learning","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0450","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3892\/ol.2023.13906","article-title":"The use of an artificial intelligence algorithm for circulating tumor cell detection in patients with esophageal cancer","volume":"26","author":"Akashi","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.trecan.2026.09.003_bb0455","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s42256-020-0153-x","article-title":"Deep learning of circulating tumour cells","volume":"2","author":"Zeune","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.trecan.2026.09.003_bb0460","doi-asserted-by":"crossref","first-page":"11057","DOI":"10.1038\/s41598-024-61378-8","article-title":"Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing","volume":"14","author":"Pastuszak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.09.003_bb0465","article-title":"A novel artificial intelligence-powered method for prediction of early recurrence of prostate cancer after prostatectomy and cancer drivers","volume":"6","author":"Huang","year":"2022","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.trecan.2026.09.003_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz096","article-title":"DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies","volume":"47","author":"Han","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2026.09.003_bb0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eng.2021.06.017","article-title":"Prediction of driver gene matching in lung cancer NOG\/PDX models based on artificial intelligence","volume":"15","author":"He","year":"2022","journal-title":"Engineering"},{"key":"10.1016\/j.trecan.2026.09.003_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02857-9","article-title":"Multimodal learning enables chat-based exploration of single-cell data","author":"Schaefer","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trecan.2026.09.003_bb0485","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2026.09.003_bb0490","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.09.003_bb0495","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nmeth.4177","article-title":"Pooled CRISPR screening with single-cell transcriptome readout","volume":"14","author":"Datlinger","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.09.003_bb0500","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","article-title":"Perturb-seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.09.003_bb0505","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41588-021-00779-1","article-title":"Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion","volume":"53","author":"Frangieh","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2026.09.003_bb0510","author":"Lin","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2026.09.003_bb0515","article-title":"Scalable probe-based single-cell transcriptional profiling for virtual cell perturbation mapping and synthetic biology phenotyping","author":"Swinderman","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2026.09.003_bb0520","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/OTT.S307546","article-title":"Artificial intelligence based on blood biomarkers including CTCs predicts outcomes in epithelial ovarian cancer: a prospective study","volume":"14","author":"Ma","year":"2021","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.trecan.2026.09.003_bb0525","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.scib.2025.04.048","article-title":"Exploring morphological heterogeneity of circulating tumor cells: machine learning-based approach for cell identification and prognostic implications","volume":"70","author":"Wang","year":"2025","journal-title":"Sci. Bull. (Beijing)"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:48:23Z","timestamp":1791492503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":105,"alternative-id":["S2405803326002141"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.09.003","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor cell\u2013immune cell clusters: dynamic engines of metastasis","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}